Published in Gastroenterology on November 01, 2001
Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci U S A (2002) 3.43
In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A (2003) 3.40
The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity. J Virol (2003) 1.90
An in vitro model of hepatitis C virion production. Proc Natl Acad Sci U S A (2005) 1.86
Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies. J Virol (2010) 1.55
Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C. Gastroenterology (2006) 1.47
Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins. Gastroenterology (2010) 1.28
Production of infectious hepatitis C virus of various genotypes in cell cultures. J Virol (2007) 1.27
Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood (2006) 1.25
Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell. J Virol (2004) 1.14
Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation. Hepatology (2008) 1.14
Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA. Proc Natl Acad Sci U S A (2003) 1.11
In vivo analysis of the 3' untranslated region of GB virus B after in vitro mutagenesis of an infectious cDNA clone: persistent infection in a transfected tamarin. J Virol (2004) 1.07
A general method for nested RT-PCR amplification and sequencing the complete HCV genotype 1 open reading frame. Virol J (2005) 1.06
Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model. J Clin Invest (2014) 0.97
Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies. J Virol (2002) 0.92
Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of hepatitis C virus genotype 1 and their relationships to pegylated interferon-ribavirin treatment responses. J Virol (2008) 0.88
Evidence for action of ribavirin through the hepatitis C virus RNA polymerase. J Viral Hepat (2009) 0.85
Hepatic transcriptome analysis of hepatitis C virus infection in chimpanzees defines unique gene expression patterns associated with viral clearance. PLoS One (2008) 0.83
Ethanol and reactive species increase basal sequence heterogeneity of hepatitis C virus and produce variants with reduced susceptibility to antivirals. PLoS One (2011) 0.83
Cell culture replication of a genotype 1b hepatitis C virus isolate cloned from a patient who underwent liver transplantation. PLoS One (2011) 0.81
Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med (2000) 5.27
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med (2000) 4.98
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A (1999) 3.30
Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest (1997) 2.99
Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J Virol (2001) 2.77
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol (1998) 2.71
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 2.59
Improvements to the SMO algorithm for SVM regression. IEEE Trans Neural Netw (2000) 2.58
Prevention of HIV infection by passive immunization with HIV immunoglobulin. AIDS Res Hum Retroviruses (1991) 2.52
Long-term therapy of chronic hepatitis B with lamivudine. Hepatology (2000) 2.49
Long-term therapy of chronic delta hepatitis with peginterferon alfa. Aliment Pharmacol Ther (2014) 2.19
A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol Cell Biol (1993) 2.12
Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci U S A (2000) 2.00
Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest (1996) 1.96
Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology (1994) 1.94
Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol (1992) 1.92
Rapid opioid detoxification during general anesthesia: a review of 20 patients. Anesthesiology (1999) 1.83
Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen. Proc Natl Acad Sci U S A (1984) 1.71
Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol (1996) 1.62
Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol (1991) 1.61
Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J Exp Med (2000) 1.59
Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol (1999) 1.57
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2008) 1.54
A polyoma mutant that encodes small T antigen but not middle T antigen demonstrates uncoupling of cell surface and cytoskeletal changes associated with cell transformation. Mol Cell Biol (1984) 1.52
Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest (1996) 1.48
Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin. Nature (1991) 1.47
Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection. Gastroenterology (2001) 1.46
Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol (1994) 1.44
DNA vaccines and viral hepatitis: are we going around in circles? Gastroenterology (1997) 1.41
Virulent HIV strains, chimpanzees, and trial vaccines. Science (1999) 1.40
Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J Biol Chem (2000) 1.39
Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J Virol (1997) 1.38
Immunopathology of hepatitis C. Springer Semin Immunopathol (1997) 1.30
X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. J Clin Invest (2001) 1.27
Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate. Gastroenterology (1999) 1.24
An AIDS-like condition induced in baboons by HIV-2. Science (1994) 1.22
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1. J Infect Dis (1996) 1.20
The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes. Aliment Pharmacol Ther (2010) 1.14
Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice. Hepatology (2001) 1.13
Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology (1991) 1.12
Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression. J Virol (1998) 1.12
Establishment of Marek's disease lymphoblastoid cell lines from transplantable versus primary lymphomas. Int J Cancer (1978) 1.11
Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy. Aliment Pharmacol Ther (2013) 1.09
Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology (2000) 1.09
Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res Hum Retroviruses (1994) 1.06
Conditional liver-specific expression of simian virus 40 T antigen leads to regulatable development of hepatic neoplasm in transgenic mice. J Biol Chem (2001) 1.05
Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B. Aliment Pharmacol Ther (2012) 1.04
Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2. AIDS (1995) 1.03
Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles. J Immunol (2001) 1.01
Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J Virol (1996) 1.01
Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus. Am J Vet Res (1979) 1.01
Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG. AIDS Res Hum Retroviruses (1992) 1.01
Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology (1997) 0.99
Association of hepatitis B viral precore mutations with fulminant hepatitis B in Japan. Virology (1991) 0.96
Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex. Proc Natl Acad Sci U S A (1999) 0.96
Disappearance of atrial natriuretic factor from circulation in the rat. Peptides (1986) 0.96
A rare case of bloody diarrhea: thrombosis of the V. mesenterica inferior following laparoscopic cholecystectomy. Z Gastroenterol (1998) 0.95
Vaccine development for hepatitis C. Semin Liver Dis (2000) 0.94
Hepatitis C: a clinical review. Oral Dis (2008) 0.94
Pathogenesis of Marek's disease: early appearance of Marek's disease tumor-associated surface antigen in infected chickens. J Natl Cancer Inst (1978) 0.94
CD8+ cells from HIV-2-infected baboons control HIV replication. AIDS (1997) 0.93
Hormonal regulation of fibrinogen synthesis in cultured hepatocytes. Ann N Y Acad Sci (1983) 0.92
Long-term assessment of arthroscopic meniscus repair: a two- to six-year follow-up study. Arthroscopy (1990) 0.92
Adenovirus vectored vaccines. Dev Biol Stand (1994) 0.92
Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen. Hum Gene Ther (1998) 0.92
HIV-1 expression in chimpanzees can be activated by CD8+ cell depletion or CMV infection. Clin Immunol Immunopathol (1992) 0.91
Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms. FASEB J (2001) 0.90
Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model. Gastroenterology (2001) 0.90
Degradation of atrial natriuretic factor in the rat. Biochem J (1986) 0.89
The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent. J Virol (1999) 0.89
Transient virus infection and pathogenesis of a new HIV type 2 isolate, UC12, in baboons. AIDS Res Hum Retroviruses (1998) 0.89
Carboxy-terminal-extended variant of the human fibrinogen alpha subunit: a novel exon conferring marked homology to beta and gamma subunits. Biochemistry (1992) 0.89
Activation signals in human lymphocytes. Incorporation of polyunsaturated fatty acids into plasma membrane phospholipids regulates IL-2 synthesis via sustained activation of protein kinase C. J Immunol (1989) 0.88
A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans. Viral Immunol (1998) 0.88
Combination therapy for hepatitis C infection. N Engl J Med (1998) 0.87
In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen. J Virol (1980) 0.87
Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection. Genes Immun (2008) 0.87
Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment. J Viral Hepat (2002) 0.87
Transmission of HCV to a chimpanzee using virus particles produced in an RNA-transfected HepG2 cell culture. J Med Virol (2001) 0.87
Undergraduate medical education in psychiatry - are we meeting the demands? Indian J Psychiatry (1988) 0.86
A humanized anti--4-1BB monoclonal antibody suppresses antigen-induced humoral immune response in nonhuman primates. J Immunother (2001) 0.85
Mechanisms of alcoholic liver disease: cytokines. Alcohol Clin Exp Res (2001) 0.85
A fast iterative nearest point algorithm for support vector machine classifier design. IEEE Trans Neural Netw (2000) 0.85
Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism (1990) 0.84
Chronic leukocytoclastic vasculitis complicating HBV infection. Possible role of mutant forms of HBV in pathogenesis and persistence of disease. J Clin Gastroenterol (1995) 0.84
New solvent-producing Clostridium sp. strains, hydrolyzing a wide range of polysaccharides, are closely related to Clostridium butyricum. J Ind Microbiol Biotechnol (2001) 0.84
Expression of B-L (Ia-like) antigens on macrophages from chicken lymphoid organs. J Immunol (1982) 0.83
Brachial plexus compression by excessive callus formation secondary to a fractured clavicle. A case report. Mt Sinai J Med (1971) 0.83
Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens. Infect Immun (1979) 0.83
Direct functional analysis of epitope-specific CD8+ T cells in peripheral blood. Viral Immunol (2001) 0.83
NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life. Peptides (1988) 0.83
Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response. J Pharm Sci (1998) 0.82
Solitary cerebral metastasis. Long-term survival following surgery. N Y State J Med (1977) 0.81